Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUPID 2 trial of MYDICAR in heart failure
2012-001700-37Phase 2Completed
- Sponsor
- Celladon Corporation
- Start
- Jun 2012
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Cardiomyopathies comparing MYDICAR plus optimal heart failure regimen with Placebo plus optimal heart failure regimen (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2012; status: completed.
02
Drugs
AAV1/SERCA2a
03
Conditions
heart failure (HF)Cardiomyopathies
Beyond the preview
Go deeper on 2012-001700-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001700-37.